RT Journal Article
SR Electronic
T1 Baerveldt glaucoma implant in paediatric patients
JF British Journal of Ophthalmology
JO Br J Ophthalmol
FD BMJ Publishing Group Ltd.
SP 328
OP 332
DO 10.1136/bjo.2005.078832
VO 90
IS 3
A1 van Overdam, K A
A1 de Faber, J T H N
A1 Lemij, H G
A1 de Waard, P W T
YR 2006
UL http://bjo.bmj.com/content/90/3/328.abstract
AB Aim: To evaluate the Baerveldt glaucoma implant (BGI) in paediatric glaucoma treatment. Methods: In a retrospective non-comparative case series 55 eyes of 40 consecutive paediatric patients (⩽16 years) with primary or secondary glaucoma underwent Baerveldt (350 mm2) implantation. Surgical outcome was evaluated by Kaplan-Meier table analysis. Results: The overall success rate was 80% at last follow up, with a mean follow up of 32 (range 2–78) months. Cumulative success was 94% at 12 months and 24 months, 85% at 36 months, 78% at 48 months, and 44% at 60 months. 11 eyes (20%) failed postoperatively because of an IOP >21 mm Hg (eight eyes), persistent hypotony (two eyes), and choroidal haemorrhage following cataract surgery (one eye). The most frequent complication needing surgery was tube related (20%). A new observation was mild to moderate dyscoria in 22% of the eyes, all buphthalmic, caused by entrapment of a tuft of peripheral iris in the tube track. Conclusions: The BGI is effective and safe in the management of primary and secondary glaucoma. When angle surgery has proved to be unsuccessful or inappropriate in paediatric patients, a BGI is a good treatment option. One must be prepared to deal with the tube related problems.